Literature DB >> 14575773

Modelling measles re-emergence as a result of waning of immunity in vaccinated populations.

Joël Mossong1, Claude P Muller.   

Abstract

An age-structured mathematical model of measles transmission in a vaccinated population is used to simulate the shift from a population whose immunity is derived from natural infection to a population whose immunity is vaccine-induced. The model incorporates waning of immunity in a population of vaccinees that eventually will become susceptible to a milder form of vaccine-modified measles with a lower transmission potential than unvaccinated classical measles. Using current estimates of duration of vaccine-derived protection, measles would not be expected to re-emerge quickly in countries with sustained high routine vaccine coverage. However, re-emergence is possible to occur several decades after introduction of high levels of vaccination. Time until re-emergence depends primarily on the contagiousness of vaccine-modified measles cases in comparison to classical measles. Interestingly, in a population with a high proportion of vaccinees, vaccine-modified measles and classical measles would occur essentially in the same age groups. Although waning of humoral immunity in vaccinees is widely observed, re-emergence of measles in highly vaccinated populations depends on parameters for which better estimates are needed.

Mesh:

Substances:

Year:  2003        PMID: 14575773     DOI: 10.1016/s0264-410x(03)00449-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  The role of maternal antibodies in the emergence of severe disease as a result of fragmentation.

Authors:  David Fouchet; Stéphane Marchandeau; Nargès Bahi-Jaber; Dominique Pontier
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  Seroprevalence of measles among Norwegian military conscripts in 2004.

Authors:  K Vainio; H H Samdal; G Anestad; D H Skutlaberg; K T Bransdal; R Mundal; I Aaberge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

3.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

4.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

5.  Immuno-epidemiology of a population structured by immune status: a mathematical study of waning immunity and immune system boosting.

Authors:  M V Barbarossa; G Röst
Journal:  J Math Biol       Date:  2015-04-02       Impact factor: 2.259

6.  Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine.

Authors:  Marcelo H Argüelles; Mariana L Orellana; Alejandro A Castello; Guillermo A Villegas; Matilde Masini; Alejandra L Belizan; Silvia González Ayala; Osmar D Vera; Graciela Glikmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

Review 8.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

9.  Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.

Authors:  F M G Magpantay; M Domenech DE Cellès; P Rohani; A A King
Journal:  Parasitology       Date:  2015-09-04       Impact factor: 3.234

10.  Asthma status and waning of measles antibody concentrations after measles immunization.

Authors:  Kwang Ha Yoo; Robert M Jacobson; Gregory A Poland; Amy Weaver; Linda Lee; Titus Chang; Young J Juhn
Journal:  Pediatr Infect Dis J       Date:  2014-10       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.